These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
255 related articles for article (PubMed ID: 32624366)
1. A comparison of three platelet function tests in ischemic stroke patients with antiplatelet therapy. Shao T; Cheng Y; Jin J; Huang L; Yang D; Luo C; Han Z; Wang Z; Ge W; Xu Y J Clin Neurosci; 2020 Aug; 78():91-96. PubMed ID: 32624366 [TBL] [Abstract][Full Text] [Related]
2. Assessment of platelet function in acute ischemic stroke patients previously treated with aspirin. Lago A; Parkhutik V; Tembl JI; Vallés J; Santos MT; Moscardó A J Stroke Cerebrovasc Dis; 2014; 23(10):2794-2799. PubMed ID: 25440364 [TBL] [Abstract][Full Text] [Related]
3. Prevalence of ex vivo high on-treatment platelet reactivity on antiplatelet therapy after transient ischemic attack or ischemic stroke on the PFA-100(®) and VerifyNow(®). Kinsella JA; Tobin WO; Cox D; Coughlan T; Collins R; O'Neill D; Murphy RP; McCabe DJ J Stroke Cerebrovasc Dis; 2013 Oct; 22(7):e84-92. PubMed ID: 22981273 [TBL] [Abstract][Full Text] [Related]
4. Platelet Function Tests Predicting the Efficacy and Safety of Aspirin Secondary Prevention. Cheng Y; Shao T; Huang L; Xu H; Shao P; Yang D; Ge W; Xu Y; Zhang M Neurol Res; 2022 Apr; 44(4):291-298. PubMed ID: 34581662 [TBL] [Abstract][Full Text] [Related]
5. High On-Treatment Platelet Reactivity to Adenosine Diphosphate Predicts Ischemic Events of Minor Stroke and Transient Ischemic Attack. Rao Z; Zheng H; Wang F; Wang A; Liu L; Dong K; Zhao X; Cao Y; Wang Y J Stroke Cerebrovasc Dis; 2017 Oct; 26(10):2074-2081. PubMed ID: 28736132 [TBL] [Abstract][Full Text] [Related]
6. Comparison between a new platelet count drop method PL-11, light transmission aggregometry, VerifyNow aspirin system and thromboelastography for monitoring short-term aspirin effects in healthy individuals. Guan J; Cong Y; Ren J; Zhu Y; Li L; Deng X; Bai J Platelets; 2015; 26(1):25-30. PubMed ID: 24433273 [TBL] [Abstract][Full Text] [Related]
7. Platelet function testing: dead or alive. Helten C; Naguib D; Dannenberg L; Pöhl M; Ayhan A; Hohlfeld T; Levkau B; Kelm M; Zeus T; Polzin A J Thromb Haemost; 2018 May; 16(5):984-986. PubMed ID: 29512292 [TBL] [Abstract][Full Text] [Related]
8. Evaluation of the role of the new INNOVANCE PFA P2Y test cartridge in detection of clopidogrel resistance. Tsantes A; Ikonomidis I; Papadakis I; Kottaridi C; Tsante A; Kalamara E; Kardoulaki A; Kopterides P; Kapsimali V; Karakitsos P; Lekakis J; Travlou A Platelets; 2012; 23(6):481-9. PubMed ID: 22646492 [TBL] [Abstract][Full Text] [Related]
10. Quantifying the effect of antiplatelet therapy: a comparison of the platelet function analyzer (PFA-100) and modified thromboelastography (mTEG) with light transmission platelet aggregometry. Agarwal S; Coakley M; Reddy K; Riddell A; Mallett S Anesthesiology; 2006 Oct; 105(4):676-83. PubMed ID: 17006064 [TBL] [Abstract][Full Text] [Related]
11. Individualized antiplatelet therapy for non-cardiogenic ischemic stroke. Zhang Y; Wang M; Su S J Stroke Cerebrovasc Dis; 2024 Jun; 33(6):107711. PubMed ID: 38580158 [TBL] [Abstract][Full Text] [Related]
13. High glycated albumin is an independent predictor of low response to clopidogrel in ACS patients: a cross-sectional study. Zhao X; Li Q; Tu C; Zeng Y; Ye Y Cardiovasc Diabetol; 2020 Oct; 19(1):171. PubMed ID: 33036613 [TBL] [Abstract][Full Text] [Related]
14. Precision and reliability of 5 platelet function tests in healthy volunteers and donors on daily antiplatelet agent therapy. Karon BS; Tolan NV; Koch CD; Wockenfus AM; Miller RS; Lingineni RK; Pruthi RK; Chen D; Jaffe AS Clin Chem; 2014 Dec; 60(12):1524-31. PubMed ID: 25281703 [TBL] [Abstract][Full Text] [Related]
15. [Evaluation of PFA P2Y assay in monitoring platelet function in elderly patients with cardiovascular disease receiving clopidogrel treatment]. Tian KP; Guan J; Cai LL; Li YR; Deng XL; Liu QY; Zheng BX; Cong YL Nan Fang Yi Ke Da Xue Xue Bao; 2016 Apr; 37(4):533-536. PubMed ID: 28446409 [TBL] [Abstract][Full Text] [Related]
16. Impact of the proton pump inhibitors and CYP2C19*2 polymorphism on platelet response to clopidogrel as assessed by four platelet function assays. Tsantes AE; Ikonomidis I; Papadakis I; Bonovas S; Gialeraki A; Kottaridi C; Kyriakou E; Kokori S; Douramani P; Kopterides P; Karakitsos P; Lekakis J; Kapsimali V Thromb Res; 2013 Aug; 132(2):e105-11. PubMed ID: 23830212 [TBL] [Abstract][Full Text] [Related]
17. Defining predictive values using three different platelet function tests for CYP2C19 phenotype status on maintenance dual antiplatelet therapy after PCI. Zhang HZ; Kim MH; Han JY; Jeong YH Platelets; 2014; 25(4):285-91. PubMed ID: 23971745 [TBL] [Abstract][Full Text] [Related]
18. Platelet function under aspirin, clopidogrel, and both after ischemic stroke: a case-crossover study. Grau AJ; Reiners S; Lichy C; Buggle F; Ruf A Stroke; 2003 Apr; 34(4):849-54. PubMed ID: 12637702 [TBL] [Abstract][Full Text] [Related]
19. Comparison of nine platelet function tests used to determine responses to different aspirin dosages in people with type 2 diabetes. Harrison P; Bethel MA; Kennedy I; Dinsdale R; Coleman R; Holman RR Platelets; 2019; 30(4):521-529. PubMed ID: 29985735 [TBL] [Abstract][Full Text] [Related]
20. High on-treatment platelet reactivity in patients with ischemic cerebrovascular disease: assessment of prevalence and stability over time using four platelet function tests. Jover E; Rodríguez JM; Bernal A; Arroyo AB; Iniesta JA; Guiú IS; Martínez C; Vicente V; Lozano ML; Rivera J Blood Coagul Fibrinolysis; 2014 Sep; 25(6):604-11. PubMed ID: 24717421 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]